Figure 1.
Biologic treatment sequences in patients with (A) Crohn's disease and (B) ulcerative colitis. ADA, adalimumab, IFX, infliximab, UST, ustekinumab; VDZ, vedolizumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.